The telecom lifted its full-year guidance again after second-quarter net profit and revenue increased, driven by growth across all its key regions. Europe's largest insurer reported a 17% rise in ...

Zepbound functions by targeting hormone receptors related to appetite regulation, specifically glucagon-like peptide-1 and ...

A trial of Eli Lilly’s diabetes drug Mounjaro did not meet expectations for outperforming Trulicity in preventing heart ...